Galderma's $1.5 Billion ZO Skin Health Deal and the Rise of Doctor-Dispensed Skincare
Cetaphil owner Galderma is buying ZO Skin Health for $1.5 billion, a big bet on physician-dispensed skincare. Here is what the deal says about where beauty is heading.